A retrospective observational study
暂无分享,去创建一个
Moon-Ho Park | Joo Hye Sung | Ileok Jung | Jin-Man Jung | M. Eun | Yong-Hyun Kim | Sang-Hun Lee | Jung Eun Son | Young Hwa Choi | Eo Jin Park | Jae Hoon Kim | Seung Ah Lee | Seung Don Yoo
[1] R. Sacco,et al. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source , 2019, The New England journal of medicine.
[2] A. Tuttolomondo,et al. HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke , 2019, Journal of Neuroinflammation.
[3] S. Rangaraju,et al. Coagulation markers and echocardiography predict atrial fibrillation, malignancy or recurrent stroke after cryptogenic stroke , 2018, Medicine.
[4] K. Cho,et al. Epicardial Fat Thickness and Free Fatty Acid Level are Predictors of Acute Ischemic Stroke with Atrial Fibrillation , 2018, Journal of cardiovascular imaging.
[5] S. Connolly,et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source , 2018, The New England journal of medicine.
[6] J. Kim,et al. Free Fatty Acid Is Associated with Thrombogenicity in Cardioembolic Stroke , 2017, Cerebrovascular Diseases.
[7] G. D. de Borst,et al. Diastolic Blood Pressure is a Risk Factor for Peri-procedural Stroke Following Carotid Endarterectomy in Asymptomatic Patients , 2017, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[8] R. Mikolajczyk,et al. Association between Embolic Stroke Patterns, ESUS Etiology, and New Diagnosis of Atrial Fibrillation: A Secondary Data Analysis of the Find-AF Trial , 2017, Stroke research and treatment.
[9] Klaus Gröschel,et al. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial , 2017, The Lancet Neurology.
[10] T. Tegos,et al. Imaging of the ulcerated carotid atherosclerotic plaque: a review of the literature , 2017, Insights into Imaging.
[11] K. Kario,et al. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation , 2016, Stroke.
[12] A. Alexandrov,et al. The value of transesophageal echocardiography for embolic strokes of undetermined source , 2016, Neurology.
[13] J. Saver,et al. CLINICAL PRACTICE. Cryptogenic Stroke. , 2016, The New England journal of medicine.
[14] Jeong-Yoon Choi,et al. Free fatty acid as an outcome predictor of atrial fibrillation–associated stroke , 2016, Annals of neurology.
[15] R. Passman,et al. Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial , 2016, Circulation. Arrhythmia and electrophysiology.
[16] H. Kamel,et al. Left Atrial Enlargement and Stroke Recurrence: The Northern Manhattan Stroke Study , 2015, Stroke.
[17] C. Buttá,et al. Peripheral Frequency of CD4+ CD28− Cells in Acute Ischemic Stroke , 2015, Medicine.
[18] G. Breithardt,et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial , 2014, European heart journal.
[19] Frank Beckers,et al. Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.
[20] S. Connolly,et al. Embolic strokes of undetermined source: the case for a new clinical construct , 2014, The Lancet Neurology.
[21] W. Tu,et al. Prognostic Value of Plasma Neuroendocrine Biomarkers in Patients with Acute Ischaemic Stroke , 2013, Journal of neuroendocrinology.
[22] B. Gersh,et al. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. , 2013, European heart journal.
[23] Y. Kim,et al. Elevated Free Fatty Acid is Associated with Cardioembolic Stroke Subtype , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[24] P. Colonna,et al. Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[25] W. März,et al. Free fatty acids as a cardiovascular risk factor , 2008, Clinical chemistry and laboratory medicine.
[26] K. Furie,et al. An evidence‐based causative classification system for acute ischemic stroke , 2005, Annals of neurology.
[27] A. Aljada,et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.
[28] R. Sacco,et al. Aortic atheromas and acute ischemic stroke , 1996, Neurology.
[29] D. Kromhout. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts , 1995, The Lancet.
[30] S. Vaziri,et al. Echocardiographic Predictors of Nonrheumatic Atrial Fibrillation: The Framingham Heart Study , 1994, Circulation.
[31] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[32] A. Weyman,et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. , 1990, Circulation.
[33] Daniel B Hier,et al. Infarcts of undetermined cause: The NINCDS stroke data bank , 1989, Annals of neurology.
[34] A. A. Spector,et al. Effect of Free Fatty Acids on ADP-induced Platelet Aggregation , 1970, Nature.
[35] W. Connor,et al. Massive thrombosis produced by fatty acid infusion. , 1963, The Journal of clinical investigation.
[36] R. Grimm,et al. Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism. , 2016, Journal of the American Society of Echocardiography.
[37] M. Siddiqui,et al. Spontaneous echo contrast in left atrial appendage during sinus rhythm. , 2001, Texas Heart Institute journal.